The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Geron Corporation(NASDAQ:GERN) 
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation ...
Website: http://www.geron.com
Founded: 1990
Full Time Employees: 45
Sector: Healthcare
Industry: Biotechnology
Geron Days Payable Outstanding ttm (DPO)
Geron Days Receivable Outstanding ttm (DSO)
Geron Days Inventory Outstanding ttm (DIO)
Geron Op Cashflow Per Share ttm
Geron Free Cashflow Per Share ttm
Geron Cash Per Share ttm
Geron P/S ratio ttm
Geron (GAAP) P/E ratio ttm
Geron P/B ratio ttm
No extra charts and metrics for this ticker.